Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT2871 | Individual Protein | Cytidine deaminase | Homo sapiens | Ki | = | 40000 | nM | 24520856 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC329077 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9054 | High Similarity | NPC325902 |
0.8395 | Intermediate Similarity | NPC43246 |
0.8395 | Intermediate Similarity | NPC89051 |
0.8293 | Intermediate Similarity | NPC163352 |
0.8293 | Intermediate Similarity | NPC210456 |
0.8272 | Intermediate Similarity | NPC325723 |
0.8125 | Intermediate Similarity | NPC319753 |
0.8095 | Intermediate Similarity | NPC315063 |
0.8026 | Intermediate Similarity | NPC315806 |
0.8025 | Intermediate Similarity | NPC106780 |
0.7927 | Intermediate Similarity | NPC71339 |
0.7927 | Intermediate Similarity | NPC112842 |
0.7727 | Intermediate Similarity | NPC17892 |
0.7727 | Intermediate Similarity | NPC36985 |
0.764 | Intermediate Similarity | NPC283698 |
0.764 | Intermediate Similarity | NPC73765 |
0.7471 | Intermediate Similarity | NPC171116 |
0.7444 | Intermediate Similarity | NPC317639 |
0.7386 | Intermediate Similarity | NPC324390 |
0.7303 | Intermediate Similarity | NPC327344 |
0.7303 | Intermediate Similarity | NPC322594 |
0.7303 | Intermediate Similarity | NPC320249 |
0.7273 | Intermediate Similarity | NPC109188 |
0.716 | Intermediate Similarity | NPC470782 |
0.7143 | Intermediate Similarity | NPC318166 |
0.7143 | Intermediate Similarity | NPC324516 |
0.7125 | Intermediate Similarity | NPC126186 |
0.7045 | Intermediate Similarity | NPC190334 |
0.7045 | Intermediate Similarity | NPC62927 |
0.6966 | Remote Similarity | NPC328806 |
0.6869 | Remote Similarity | NPC329277 |
0.6796 | Remote Similarity | NPC478024 |
0.6733 | Remote Similarity | NPC155087 |
0.6733 | Remote Similarity | NPC149843 |
0.6705 | Remote Similarity | NPC229249 |
0.6667 | Remote Similarity | NPC470781 |
0.6552 | Remote Similarity | NPC470783 |
0.6526 | Remote Similarity | NPC6166 |
0.6526 | Remote Similarity | NPC226769 |
0.6526 | Remote Similarity | NPC280946 |
0.6486 | Remote Similarity | NPC293551 |
0.6458 | Remote Similarity | NPC120887 |
0.6458 | Remote Similarity | NPC90240 |
0.6438 | Remote Similarity | NPC275727 |
0.6392 | Remote Similarity | NPC328779 |
0.6338 | Remote Similarity | NPC224624 |
0.6322 | Remote Similarity | NPC312315 |
0.6296 | Remote Similarity | NPC34291 |
0.6296 | Remote Similarity | NPC126664 |
0.6296 | Remote Similarity | NPC316445 |
0.6282 | Remote Similarity | NPC243964 |
0.6263 | Remote Similarity | NPC328914 |
0.625 | Remote Similarity | NPC128005 |
0.625 | Remote Similarity | NPC84182 |
0.6125 | Remote Similarity | NPC233034 |
0.6082 | Remote Similarity | NPC329384 |
0.6061 | Remote Similarity | NPC313821 |
0.6019 | Remote Similarity | NPC314413 |
0.6019 | Remote Similarity | NPC314398 |
0.6019 | Remote Similarity | NPC239705 |
0.6 | Remote Similarity | NPC475542 |
0.5962 | Remote Similarity | NPC322449 |
0.5962 | Remote Similarity | NPC92874 |
0.5962 | Remote Similarity | NPC166242 |
0.5962 | Remote Similarity | NPC189854 |
0.5962 | Remote Similarity | NPC62845 |
0.5952 | Remote Similarity | NPC223174 |
0.5952 | Remote Similarity | NPC327753 |
0.5952 | Remote Similarity | NPC327486 |
0.5948 | Remote Similarity | NPC315058 |
0.5913 | Remote Similarity | NPC325750 |
0.5905 | Remote Similarity | NPC10897 |
0.5905 | Remote Similarity | NPC325900 |
0.5904 | Remote Similarity | NPC171850 |
0.5904 | Remote Similarity | NPC474469 |
0.5897 | Remote Similarity | NPC170172 |
0.5882 | Remote Similarity | NPC196007 |
0.5882 | Remote Similarity | NPC76297 |
0.5882 | Remote Similarity | NPC214532 |
0.5862 | Remote Similarity | NPC284651 |
0.5854 | Remote Similarity | NPC12514 |
0.5854 | Remote Similarity | NPC294883 |
0.5833 | Remote Similarity | NPC475715 |
0.5833 | Remote Similarity | NPC475127 |
0.5833 | Remote Similarity | NPC275715 |
0.5833 | Remote Similarity | NPC473419 |
0.5802 | Remote Similarity | NPC163134 |
0.5802 | Remote Similarity | NPC471419 |
0.5798 | Remote Similarity | NPC313962 |
0.5783 | Remote Similarity | NPC184150 |
0.5783 | Remote Similarity | NPC141156 |
0.5765 | Remote Similarity | NPC115800 |
0.5765 | Remote Similarity | NPC163538 |
0.5747 | Remote Similarity | NPC266888 |
0.5747 | Remote Similarity | NPC161774 |
0.5747 | Remote Similarity | NPC256312 |
0.5747 | Remote Similarity | NPC209156 |
0.5714 | Remote Similarity | NPC254617 |
0.5714 | Remote Similarity | NPC74555 |
0.5714 | Remote Similarity | NPC266242 |
0.5714 | Remote Similarity | NPC306763 |
0.5684 | Remote Similarity | NPC469363 |
0.5667 | Remote Similarity | NPC314772 |
0.5667 | Remote Similarity | NPC314968 |
0.5652 | Remote Similarity | NPC476302 |
0.5641 | Remote Similarity | NPC311668 |
0.5641 | Remote Similarity | NPC65832 |
0.5641 | Remote Similarity | NPC10262 |
0.5631 | Remote Similarity | NPC475440 |
0.5619 | Remote Similarity | NPC314387 |
0.5612 | Remote Similarity | NPC475801 |
0.5612 | Remote Similarity | NPC474593 |
0.5604 | Remote Similarity | NPC316807 |
0.5604 | Remote Similarity | NPC31756 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC329077 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.8395 | Intermediate Similarity | NPD9580 | Clinical (unspecified phase) |
0.8395 | Intermediate Similarity | NPD9581 | Clinical (unspecified phase) |
0.8095 | Intermediate Similarity | NPD755 | Phase 3 |
0.8026 | Intermediate Similarity | NPD9653 | Clinical (unspecified phase) |
0.8 | Intermediate Similarity | NPD9556 | Approved |
0.7927 | Intermediate Similarity | NPD280 | Approved |
0.7901 | Intermediate Similarity | NPD9560 | Approved |
0.7901 | Intermediate Similarity | NPD9561 | Approved |
0.7831 | Intermediate Similarity | NPD9557 | Clinical (unspecified phase) |
0.7805 | Intermediate Similarity | NPD9546 | Phase 2 |
0.7805 | Intermediate Similarity | NPD9559 | Phase 1 |
0.7778 | Intermediate Similarity | NPD9558 | Phase 3 |
0.7738 | Intermediate Similarity | NPD240 | Phase 3 |
0.7738 | Intermediate Similarity | NPD170 | Approved |
0.7711 | Intermediate Similarity | NPD9533 | Phase 2 |
0.7654 | Intermediate Similarity | NPD9429 | Discontinued |
0.7647 | Intermediate Similarity | NPD241 | Discontinued |
0.764 | Intermediate Similarity | NPD9639 | Clinical (unspecified phase) |
0.7595 | Intermediate Similarity | NPD9407 | Approved |
0.7529 | Intermediate Similarity | NPD9562 | Discovery |
0.75 | Intermediate Similarity | NPD238 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD239 | Phase 2 |
0.7473 | Intermediate Similarity | NPD502 | Approved |
0.7471 | Intermediate Similarity | NPD841 | Approved |
0.747 | Intermediate Similarity | NPD2691 | Clinical (unspecified phase) |
0.7386 | Intermediate Similarity | NPD9565 | Discontinued |
0.7381 | Intermediate Similarity | NPD9529 | Phase 1 |
0.7303 | Intermediate Similarity | NPD251 | Approved |
0.7273 | Intermediate Similarity | NPD1331 | Approved |
0.7241 | Intermediate Similarity | NPD1760 | Approved |
0.7222 | Intermediate Similarity | NPD1686 | Approved |
0.7215 | Intermediate Similarity | NPD9405 | Approved |
0.7143 | Intermediate Similarity | NPD501 | Phase 1 |
0.7128 | Intermediate Similarity | NPD223 | Clinical (unspecified phase) |
0.7083 | Intermediate Similarity | NPD1061 | Clinical (unspecified phase) |
0.7045 | Intermediate Similarity | NPD9603 | Phase 3 |
0.7045 | Intermediate Similarity | NPD9602 | Phase 3 |
0.7045 | Intermediate Similarity | NPD9604 | Approved |
0.6989 | Remote Similarity | NPD762 | Discontinued |
0.6939 | Remote Similarity | NPD3128 | Phase 3 |
0.6869 | Remote Similarity | NPD3129 | Phase 3 |
0.6739 | Remote Similarity | NPD9585 | Discontinued |
0.6739 | Remote Similarity | NPD6943 | Clinical (unspecified phase) |
0.6705 | Remote Similarity | NPD9601 | Approved |
0.67 | Remote Similarity | NPD1385 | Discontinued |
0.6667 | Remote Similarity | NPD9573 | Phase 2 |
0.6667 | Remote Similarity | NPD5789 | Clinical (unspecified phase) |
0.6667 | Remote Similarity | NPD279 | Clinical (unspecified phase) |
0.6465 | Remote Similarity | NPD7651 | Approved |
0.6458 | Remote Similarity | NPD514 | Clinical (unspecified phase) |
0.6444 | Remote Similarity | NPD9555 | Phase 2 |
0.6413 | Remote Similarity | NPD9553 | Approved |
0.6413 | Remote Similarity | NPD301 | Discontinued |
0.6413 | Remote Similarity | NPD9554 | Approved |
0.641 | Remote Similarity | NPD9211 | Clinical (unspecified phase) |
0.6364 | Remote Similarity | NPD9600 | Approved |
0.6355 | Remote Similarity | NPD3138 | Phase 3 |
0.6321 | Remote Similarity | NPD7914 | Suspended |
0.6296 | Remote Similarity | NPD3139 | Phase 3 |
0.6296 | Remote Similarity | NPD9443 | Clinical (unspecified phase) |
0.6277 | Remote Similarity | NPD267 | Discontinued |
0.6264 | Remote Similarity | NPD9401 | Discovery |
0.6263 | Remote Similarity | NPD1455 | Phase 3 |
0.6263 | Remote Similarity | NPD1454 | Phase 3 |
0.6222 | Remote Similarity | NPD9572 | Clinical (unspecified phase) |
0.6125 | Remote Similarity | NPD9440 | Discontinued |
0.6105 | Remote Similarity | NPD500 | Discontinued |
0.6082 | Remote Similarity | NPD215 | Discontinued |
0.6061 | Remote Similarity | NPD3191 | Approved |
0.6061 | Remote Similarity | NPD3190 | Approved |
0.6061 | Remote Similarity | NPD3189 | Approved |
0.6044 | Remote Similarity | NPD883 | Phase 2 |
0.6044 | Remote Similarity | NPD882 | Phase 2 |
0.6042 | Remote Similarity | NPD285 | Discontinued |
0.6026 | Remote Similarity | NPD9455 | Approved |
0.6 | Remote Similarity | NPD9504 | Approved |
0.6 | Remote Similarity | NPD9503 | Approved |
0.5962 | Remote Similarity | NPD6946 | Approved |
0.5952 | Remote Similarity | NPD9445 | Approved |
0.5949 | Remote Similarity | NPD393 | Approved |
0.5909 | Remote Similarity | NPD372 | Clinical (unspecified phase) |
0.5904 | Remote Similarity | NPD9444 | Discontinued |
0.5865 | Remote Similarity | NPD2633 | Phase 1 |
0.5842 | Remote Similarity | NPD192 | Phase 2 |
0.5833 | Remote Similarity | NPD1805 | Phase 2 |
0.5833 | Remote Similarity | NPD1804 | Phase 2 |
0.5755 | Remote Similarity | NPD1428 | Phase 2 |
0.5729 | Remote Similarity | NPD3177 | Phase 3 |
0.5714 | Remote Similarity | NPD4743 | Phase 2 |
0.5667 | Remote Similarity | NPD9434 | Approved |
0.5667 | Remote Similarity | NPD9435 | Approved |
0.5648 | Remote Similarity | NPD6693 | Phase 3 |
0.5625 | Remote Similarity | NPD9239 | Approved |
0.5625 | Remote Similarity | NPD9240 | Approved |
0.5619 | Remote Similarity | NPD3185 | Approved |
0.5619 | Remote Similarity | NPD3183 | Approved |
0.5619 | Remote Similarity | NPD3184 | Approved |
0.5619 | Remote Similarity | NPD3182 | Approved |
0.56 | Remote Similarity | NPD1706 | Clinical (unspecified phase) |
PubChem CID   | 94312 |
ChEMBL   | CHEMBL3237555 |
ZINC   |
Molecular Weight:   | 246.09 |
ALogP:   | -2.3402 |
MLogP:   | 1.57 |
XLogP:   | -2.067 |
# Rotatable Bonds:   | 6 |
Polar Surface Area:   | 122.82 |
# H-Bond Aceptor:   | 8 |
# H-Bond Donor:   | 4 |
# Rings:   | 2 |
# Heavy Atoms:   | 17 |